E-DRUG Archives (by date)

• Thread Index

October 31, 1999
• E-DRUG: Promoting Rational Drug Use Course Nigeria Jan 2000
  • From: Richardl Laing <richardl@bu.edu>
• E-DRUG: TB combinations in kenya
  • From: "sksharif" <sksharif@africaonline.co.ke>
October 30, 1999
• E-DRUG: TB drug combinations
  • From: <dda@ddazz.healthnet.org.np>
• E-DRUG: Prescribing in the Elderly (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
October 29, 1999
• E-DRUG: Priceless definition of advertising
  • From: Sid Wolfe <swolfe@citizen.org>
• E-DRUG: Prescribing for the Elderly (cont)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• E-DRUG: TB report
  • From: Richard Laing <richardl@bu.edu>
• E-DRUG: Prescribing in the Elderly (cont)
  • From: Barbara Mielke <bmielke@pbm.co.za>
• E-DRUG: Prescribing for the Elderly (cont)
  • From: "Joncheere, Kees de (QCP-PHA)" <CJO@who.dk>
• E-DRUG: generic manufacturers (cont)
  • From: "Joncheere, Kees de (QCP-PHA)" <CJO@who.dk>
• E-DRUG: Prescribing for the Elderly
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: generic manufacturers (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: Prescribing for the Elderly
  • From: David Woods <david.woods@stonebow.otago.ac.nz>
• E-DRUG: NYT: Rising Cost of Drugs
  • From: e-drug@usa.healthnet.org
• E-DRUG: Malaysian PM about access to drugs
  • From: "Eric Goemaere" <goemaere@mweb.co.za>
October 28, 1999
• E-DRUG: NIH Director, Harold Varmus
  • From: "Khalil Elouardighi" <gerrold@wanadoo.fr>
• E-DRUG: Prescribing for the Elderly
  • From: Essential Drugs Project <edp@gn.apc.org>
• E-DRUG: Tuberculosis: WHO Supports New, More Expensive Strategy
  • From: "Richard Laing" <richardl@bu.edu>
• [no subject]
  • From: owner-e-drug@usa.healthnet.org
• E-DRUG: Drug alert - Antibiotic withdrawn (contd)
  • From: ahmads@cder.fda.gov
• E-DRUG: Drug alert - Antibiotic withdrawn
  • From: "Dr. Anne Holbrook" <holbrook@fhs.csu.mcmaster.ca>
• E-DRUG: Note on imports of drugs under Compulsory license
  • From: James Love <love@cptech.org>
• E-DRUG: Letter from NIH Director, Harold Varmus
  • From: "admin" <admin@worldccr.org>
• E-DRUG: STD control and HIV prevention
  • From: e-drug@usa.healthnet.org
October 27, 1999
• E-DRUG: Drug alert - Antibiotic withdrawn
  • From: ahmads@cder.fda.gov
• E-DRUG: Letter from NIH Director, Harold Varmus
  • From: "Dr Wilbert Bannenberg, SADAP coordinator" <bannew@hltrsa.pwv.gov.za>
• E-DRUG: Anti retrovirals (cont)
  • From: James Love <love@cptech.org>
• E-DRUG: Anti retrovirals (cont)
  • From: Scondras@aol.com
• E-DRUG: Anti retrovirals (cont)
  • From: Carolyn Green <greencm@dial.pipex.com>
October 26, 1999
• E-DRUG: Controlling Publication of Clinical Trials
  • From: Larry Sasich <lsasich@citizen.org>
• E-DRUG: new book on prescribing
  • From: A/Prof Andrea Mant <A.Mant@unsw.EDU.AU>
• E-DRUG: ATC classification (cont)
  • From: Beverley Snell <bev@burnet.edu.au>
October 25, 1999
• E-DRUG: Anti retrovirals (cont)
  • From: James Love <love@cptech.org>
• E-DRUG: Consultation draft WHO Guidelines on Interaction with Commercial
  • From: "Bas" <Bas@hai.antenna.nl>
• E-DRUG: Anti retrovirals (cont)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• E-DRUG: Anti retrovirals (cont)
  • From: Carolyn Green <greencm@dial.pipex.com>
• E-DRUG: World Bank study
  • From: Jerome.Dumoulin@upmf-grenoble.fr
• E-DRUG: ATC classification (cont)
  • From: sjappe@online.no"Stein Lyftingsmo"
October 24, 1999
• E-DRUG: generic anti retrovirals (cont)
  • From: "Richard Laing" <richardl@bu.edu>
• E-DRUG: generic anti retrovirals (cont)
  • From: "Khalil Elouardighi" <gerrold@wanadoo.fr>
• E-DRUG: generic anti retrovirals (cont)
  • From: Scondras@aol.com
October 22, 1999
• E-DRUG: Managed Care and Prescription Drugs, Please help us!
  • From: Alexandra Regalia <Aregalia@msh.org>
• E-DRUG: USP posts Guide for Evaluating Consumer Materials on Web site
  • From: "Pat Bush" <pjb@usp.org>
• E-DRUG: World Bank study
  • From: msmith@oxfam.org.uk
• E-DRUG: ATC classification (cont)
  • From: whocc@nmd.no
• E-DRUG: ATC classification - WHO collaborating centre
  • From: Jorg Hetzke <hetzkej@who.ch>
October 21, 1999
• E-DRUG: ATC classification (cont)
  • From: Beverley Snell <bev@burnet.edu.au>
• E-DRUG: Non drug CB therapy is better for many psychiatric conditions!
  • From: "Peter Mansfield" <peter.mansfield@flinders.edu.au>
• E-DRUG: Infodev scholarship fund
  • From: Leela McCullough <leela@usa.healthnet.org>
• E-DRUG: Increasing Access to Essential Drugs in a Globalised Economy
  • From: "Bas" <Bas@hai.antenna.nl>
• E-DRUG: Paris R&D Workshop -- Statement
  • From: Daniel_BERMAN@geneva.msf.org (Daniel BERMAN)
• E-DRUG: generic fluconazole, ciprofloxacin, AZT? (cont)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• E-DRUG: pharmaceutical marketing
  • From: "Altynai" <altynai@gkkn.mail.kg>
• E-DRUG: ATC classification
  • From: "halima rahmtoola" <halimar@transmed.co.za>
• E-DRUG: STGs for psychiatric conditions needed (cont)
  • From: "Leona Coetzer" <ppc@comed.pwv.gov.za>
• E-DRUG: Pharmacists et al
  • From: "Susan Buekes" <buekes@mweb.co.za>
• E-DRUG: STGs for psychiatric conditions needed (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: NEW: Therapeutics Letter 31 now available on the web
  • From: "Ciprian Jauca" <jauca@ti.ubc.ca>
October 20, 1999
• E-DRUG: bio-ethics in developing countries
  • From: Yvonne Melia <ymelia@nuffieldfoundation.org>
• [no subject]
  • From: "Tzafou, Anny" <at92023@glaxowellcome.co.uk>, "Steta, Amir"@usa.healthnet.org
• E-DRUG: generic fluconazole, ciprofloxacin, AZT? (cont)
  • From: farmaka@online.be
• E-DRUG: STGs for psychiatric conditions needed (cont)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• E-DRUG: generic fluconazole, ciprofloxacin, AZT?
  • From: Wilbert Bannenberg <bannew@hltrsa.pwv.gov.za>
• E-DRUG: drug scheduling (cont)
  • From: couperm@who.ch
• E-DRUG: STGs for psychiatric conditions needed (cont)
  • From: mdb@amsterdam.msf.org
• E-DRUG: Vaccine trial guidelines (cont)
  • From: Yvonne Melia <ymelia@nuffieldfoundation.org>
• E-DRUG: drug scheduling (cont)
  • From: Stewart_Jessamine@moh.govt.nz
• E-DRUG: Developing nation pharmacist's perspective
  • From: "J. Maundu" <thitu@u.washington.edu>
October 19, 1999
• E-DRUG: Request for information
  • From: Aryanti Radyowijati <Aryanti@Compuserve.com>
• E-DRUG: WTO: What Strategies for the South?
  • From: Paul <Paul@southcentre.org>
• E-DRUG: Nurses and rational drug use
  • From: "Andy Gray" <andy@healthlink.org.za>
• E-DRUG: Yale research produced d4T and 3TC
  • From: thiru balasubramaniam <thiru@cptech.org>
• E-DRUG: MSF wins NOBEL PEACE PRIZE
  • From: thiru balasubramaniam <thiru@cptech.org>
• E-DRUG: Vaccine trial guidelines?
  • From: "Liz Dartnall" <dartnl@HLTRSA2.PWV.GOV.ZA>
• E-DRUG: Request for nominations for WHO Expert Panel
  • From: WHO/EDM <hogerzeilh@who.ch>
• E-DRUG: drug scheduling (cont)
  • From: couperm@who.ch
• E-DRUG: drug scheduling
  • From: journal@pharma.viaduk.net
• E-DRUG: Somali Group for Rational Use of Drugs
  • From: Abdullahi Elmi <somali_drugs@yahoo.com>
October 18, 1999
• E-DRUG: Reporting Questionable Drug Donations (cont)
  • From: JBRusso@aol.com
• E-DRUG: Pharmacy drivers/counselling etc (cont)
  • From: Audrey Robinson <AudreyR@qualsa.co.za>
• E-DRUG: 'burdens' and 'prevalence' (cont)
  • From: Jody Dalmacion <jrvd1953@yahoo.com>
• E-DRUG: 'burdens' and 'prevalence' (cont)
  • From: "J. Maundu" <thitu@u.washington.edu>
• E-DRUG: 'burdens' and 'prevalence'
  • From: "Leona Coetzer" <ppc@comed.pwv.gov.za>
October 17, 1999
• E-DRUG: Drug research and development
  • From: toole@burnet.edu.au
• E-DRUG: WHO Press Release on Good Drug Donations (cont)
  • From: "Ellen 't Hoen" <ethoen@compuserve.com>
• E-DRUG: Polypharmacy in India (cont)
  • From: "ARUN BAL" <balarun@hotmail.com>
• E-DRUG: DTC advertising, marketing of depression and World Health
  • From: "Charles Medawar" <charles@socialaudit.org.uk>
• E-DRUG: pharmacy in Argentina
  • From: "CAPEMVEL" <capemvel.otc@datamarkets.com.ar>
• E-DRUG: The Importance of Declared Interests
  • From: "Mariam Cassimjee" <mimi@iafrica.com>
• E-DRUG: Indian Medical Association
  • From: "hanumantha potharaju" <drphrao@hotmail.com>
• E-DRUG: NSAIDs in your EDL
  • From: AIS NICARAGUA <aisnic@ibw.com.ni>
October 15, 1999
• E-DRUG: TB treatment in Cameroon (cont)
  • From: hospital_banso@kastanet.org
• E-DRUG: pharmacy drivers (cont)
  • From: B.Futter@ru.ac.za
• E-DRUG: WHO Press Release on Good Drug Donations (cont)
  • From: JBRusso@aol.com
• E-DRUG: Essential drugs in Tokyo University (cont)
  • From: "Ngoyi Bukonda" <r90nkb1@wpo.cso.niu.edu>
• E-DRUG: pharmacy drivers, counselling (cont)
  • From: "Rina Meyer" <FKLCLM@puknet.puk.ac.za>
• E-DRUG: Rotavirus vaccine withdrawn
  • From: srahmad@essential.org
October 14, 1999
• E-DRUG: Essential drugs in Tokyo University (cont)
  • From: "Ngoyi Bukonda" <r90nkb1@wpo.cso.niu.edu>
• E-DRUG: Essential drugs in Tokyo University (cont)
  • From: Dzulkifli Abdul Razak <dzul@prn.usm.my>
• E-DRUG: Essential drugs in Tokyo University (cont)
  • From: "Takeo Saio" <saio@ppp.bekkoame.ne.jp>
• E-DRUG: Polypharmacy in India - Measures to be taken
  • From: B Ekbal <ekbal@vsnl.com>
October 13, 1999
• E-DRUG: pharmacy drivers (cont)
  • From: PETER EAGLES <PEAGLES@uwc.ac.za>
• E-DRUG: Polypharmacy in India (cont)
  • From: "Staffan Svensson" <staffan.svensson@pharm.gu.se>
• E-DRUG: International Ethics Codes Update
  • From: Peter Lurie <plurie@citizen.org>
• E-DRUG: Why Compound 64937 will never see light of day
  • From: Daniel_BERMAN@geneva.msf.org (Daniel BERMAN)
• E-DRUG: Polypharmacy in India (cont)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• E-DRUG: Essential drugs in Tokyo University (cont)
  • From: sesaym@who.ch
• E-DRUG: Polypharmacy in India (cont)
  • From: "Sivasankaran Ponnusankar" <ponnusankarsivas@hotmail.com>
• E-DRUG: Polypharmacy in India (cont)
  • From: RAJ VAIDYA <pharmhin@goa1.dot.net.in>
• E-DRUG: WHO Press Release on Good Drug Donations (cont)
  • From: Doctopuz@aol.com
October 12, 1999
• E-DRUG: WHO Press Release on Good Drug Donations
  • From: hartlg@who.ch
• E-DRUG: Essential drugs in Tokyo University
  • From: Takeo.Saio" <saio@ppp.bekkoame.ne.jp>"@usa.healthnet.org
• E-DRUG: Access to the WHO List of Essential Drugs (cont)
  • From: Dzulkifli Abdul Razak <dzul@prn.usm.my>
October 11, 1999
• E-DRUG: Access to the WHO List of Essential Drugs
  • From: "Ngoyi Bukonda" <r90nkb1@wpo.cso.niu.edu>
• E-DRUG: Polypharmacy in India
  • From: RAJ VAIDYA <pharmhin@goa1.dot.net.in>
• E-DRUG: To dispense or not to dispense (cont)
  • From: Siyad Abdullahi <siyad@bu.edu>
• E-DRUG: Formulary and essential drug list
  • From: Jody Dalmacion <jrvd1953@yahoo.com>
October 09, 1999
• E-DRUG: US Orphan Drug Act and the price of Oxandrolone
  • From: James Love <love@cptech.org>
• E-DRUG: Article in BMJ on 'appropriate donations' (cont)
  • From: "Michael R. Reich" <reich@hsph.harvard.edu>
• E-DRUG: 10th ed WHO Model Essential Drug List
  • From: Dzulkifli Abdul Razak <dzul@prn.usm.my>
• E-DRUG: TB Treatment in Cameroon
  • From: hospital_banso@kastanet.org
• Re: E-DRUG: AZT patented?
  • From: Teka AbaMacha <abamacha@home.com>
• E-DRUG: generic drugs and medical supplies suppliers, purchasers
  • From: Daniel Vandenbergh <dvandenbergh@aedes.be>
• Re: E-DRUG: AZT patented?
  • From: James Love <love@cptech.org>
• Re: E-DRUG: Pharmacists et al
  • From: "Ngoyi Bukonda" <r90nkb1@wpo.cso.niu.edu>
• Re: E-DRUG: Pharmacy Drivers
  • From: Timothy Dodd <Cath_and_Tim_Dodd@compuserve.com>
October 08, 1999
• E-DRUG: Quality of Life Assessment
  • From: "Kassim A. Al-Riyamy" <qasr@hotmail.com>
• E-DRUG: US Orphan Drug Act and the price of Oxandrolone
  • From: James Love <love@cptech.org>
• E-DRUG: Essential drugs in Tokyo University
  • From: "Kassim A. Al-Riyamy" <qasr@hotmail.com>
• E-DRUG: Article in BMJ on 'appropriate donations'
  • From: "Mark Raijmakers, Wemos" <mark.raijmakers@wemos.nl>
• E-DRUG: skin lightening pills
  • From: "ew 2000" <ew_2000@hotmail.com>
• E-DRUG: Australian Prescriber Oct 1999
  • From: Susan Reid <Susan.Reid@health.gov.au>
• E-DRUG: re: Baralgan in India
  • From: ctddsf@vsnl.com
• Re: E-DRUG: 10th ed WHO Model Essential Drug List
  • From: commonc@who.ch
• E-DRUG: To dispense or not to dispense
  • From: Abdullahi Elmi <somali_drugs@yahoo.com>
• E-DRUG: Articles from BMJ 9 Oct 1999; Vol. 319, No. 7215
  • From: Dzulkifli Abdul Razak <dzul@prn.usm.my>
October 07, 1999
• Re: E-DRUG: AZT patented?
  • From: Teka AbaMacha <abamacha@home.com>
October 06, 1999
• Re: E-DRUG: AZT patented?
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• E-DRUG: Pharmacists et al
  • From: David Gilbert <DGilbert@OPM.Co.UK>
• E-DRUG: nimesulide safety in chronic use?
  • From: "Sivasankaran Ponnusankar" <ponnusankarsivas@hotmail.com>
• E-DRUG: Analgin as an antispasmodic & Hoechst's marketing
  • From: RAJ VAIDYA <pharmhin@goa1.dot.net.in>
• RE: E-DRUG: Colombian Orphan Drugs Bill
  • From: "Joncheere, Kees de (QCP-PHA)" <CJO@who.dk>
• E-DRUG: 10th ed WHO Model Essential Drug List
  • From: Dzulkifli Abdul Razak <dzul@prn.usm.my>
• E-DRUG: Nader/CPT/EI letter to USTR/Barshefsky
  • From: James Love <love@cptech.org>
• E-DRUG: Evidence for drug regimens
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
October 05, 1999
• E-DRUG: Withdrawal of antipsychotics in Pakistan
  • From: Joan-Ramon Laporte <Joan.Laporte@uab.es>
• E-DRUG: Colombian Orphan Drugs Bill
  • From: Rodolfo Dennis Verano <rdennis@javercol.javeriana.edu.co>
• Re: E-DRUG: Nimesulide safety?
  • From: Maurizio Bonati <MOTHER_CHILD@irfmn.mnegri.it>
• E-DRUG: AZT patented?
  • From: msmith@oxfam.org.uk
• E-DRUG: Contents Prescrire International, Oct 99. Vol. 8, Nr 43
  • From: "Prescrire / International " <internat@prescrire.org>
• Re: E-DRUG: The terms compliance and concordance
  • From: TBuclin <tbuclin@chuv.hospvd.ch>
• E-DRUG: primary health care clinic dispensaries
  • From: Wilbert Bannenberg <WilbertBannenberg@compuserve.com>
• Re: E-DRUG: Affordable prescription drugs Act (USA)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
October 04, 1999
• E-DRUG: Quality of Life Assessment
  • From: "Rina Meyer" <FKLCLM@puknet.puk.ac.za>
• Re: E-DRUG: Pharmcists' Counselling
  • From: kdep <kdep@healthnet.or.ke>
• E-DRUG: Yellow Book in Spanish and French
  • From: Jim Rankin <JRANKIN@msh.org>
• E-DRUG: pharmacy drivers -Reply
  • From: "Rina Meyer" <FKLCLM@puknet.puk.ac.za>
• Re: E-DRUG: Quality of Life Assessment
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• Re: E-DRUG: Affordable prescription drugs Act (USA)
  • From: "admin" <admin@worldccr.org>
• E-DRUG: primary health care clinic dispensaries
  • From: Adrie Mandrekar <mandrekar@memisa.nl>
• Re: E-DRUG: Pharmacy Drivers
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• Re: E-DRUG: Dispensing Doctors
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• RE: E-DRUG: The terms compliance and patient
  • From: "Anthony Klouda" <anthonyk@aklouda.demon.co.uk>
• Re: E-DRUG: Pharmcists' Counselling
  • From: ceci <cecilia@gpu.srv.ualberta.ca>
• E-DRUG: Amayeza Drug Information Centre, SA launched
  • From: hamis@iafrica.com
• E-DRUG: MSF web site on access to medicines
  • From: "Andy Gray" <andy@healthlink.org.za>
• E-DRUG: Scottish prescribing quality
  • From: "Andy Gray" <andy@healthlink.org.za>
• E-DRUG: Affordable prescription drugs Act (USA)
  • From: James Love <love@cptech.org>
• E-DRUG: HR 2927 Bill on compulsory licensing in USA
  • From: James Love <love@cptech.org>
• E-DRUG: Congressman S.Brown's letter to America's Pharmac.CEOs
  • From: James Love <love@cptech.org>
• E-DRUG: Health on the Net Foundation
  • From: Health on the Net Foundation <webmaster@hon.ch>
October 03, 1999
• Re: E-DRUG: Re Dispensing Doctors
  • From: "magagula" <magmu@realnet.co.sz>
• Re: E-DRUG: The terms compliance and patient
  • From: "Lucas Pinxten and Ime Bressers" <lpinxten@knmg.nl>
• E-DRUG: Abortion device from Norway
  • From: "Women's Global Network on reproductive Rights" <office@wgnrr.nl>
• E-DRUG: E-Drug: Ethical Rules, Changes and Lawyer's Questions
  • From: "Mariam Cassimjee" <mimi@iafrica.com>
• Re: E-DRUG: Dispensing Doctors
  • From: "Mariam Cassimjee" <mimi@iafrica.com>
• Re: E-DRUG: The terms compliance and patient
  • From: "Lucas Pinxten and Ime Bressers" <lpinxten@knmg.nl>
October 02, 1999
• E-DRUG: Pharmcists' Counselling
  • From: "Chris W. Green" <chrisg@rad.net.id>
• E-DRUG: Re: The terms compliance and concordance
  • From: David Dickinson <david.dickinson@consumation.com>
• Re: E-DRUG: The Yellow Book in spanish/french?
  • From: "Msafiri Kweba" <jandwa@osh.namib.com>
• E-DRUG: Nimesulide safety?
  • From: "Sivasankaran Ponnusankar" <ponnusankarsivas@hotmail.com>
• Re: E-DRUG: Millions for Viagra, Pennies for the Poor
  • From: lo@euronet.nl
• Re: E-DRUG: Why donations of sample/outdated drugs are welcome
  • From: lo@euronet.nl
October 01, 1999
• E-DRUG: Re Dispensing Doctors
  • From: Timothy Dodd <Cath_and_Tim_Dodd@compuserve.com>
• E-DRUG: The Yellow Book in spanish/french?
  • From: Natalia Herce <nherce@unav.es>
• E-DRUG: RE: To Dispense or not to dispense
  • From: "Defty, Douglas" <douglas.defty@mediclinic.co.za>
• E-DRUG: Re Pharmacy Drivers
  • From: Timothy Dodd <Cath_and_Tim_Dodd@compuserve.com>
• E-DRUG: Quality of Life Assessment
  • From: "Jatinder Singh" <jatindersingh@vsnl.com>
• E-DRUG: U.S. Campaign on Safe Use of Meds
  • From: srahmad@essential.org
• E-DRUG: essential drugs in Tokyo University
  • From: Francisco Flores <panchoflores@yahoo.com>
• Re: E-DRUG: To Dispense or not to dispense
  • From: A/Prof Andrea Mant <A.Mant@unsw.EDU.AU>
• E-DRUG: pharmacy in Argentina
  • From: "karina y adrian" <kariadri@cvtci.com.ar>
• Re: E-DRUG: pharmacy drivers
  • From: e-drug@usa.healthnet.org